These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29345880)

  • 1. Strategies for Managing Patients With Depression Who Are Experiencing Cognitive Impairment.
    Culpepper L
    J Clin Psychiatry; 2017; 78(9):e1432. PubMed ID: 29345880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management.
    Culpepper L; Lam RW; McIntyre RS
    J Clin Psychiatry; 2017; 78(9):1383-1394. PubMed ID: 29345866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive remission: a novel objective for the treatment of major depression?
    Bortolato B; Miskowiak KW; Köhler CA; Maes M; Fernandes BS; Berk M; Carvalho AF
    BMC Med; 2016 Jan; 14():9. PubMed ID: 26801406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procognitive Effects of Antidepressants and Other Therapeutic Agents in Major Depressive Disorder: A Systematic Review.
    Blumberg MJ; Vaccarino SR; McInerney SJ
    J Clin Psychiatry; 2020 Jul; 81(4):. PubMed ID: 32726521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Treatment of Cognitive Symptoms in Major Depressive Disorder.
    Pan Z; Grovu RC; Cha DS; Carmona NE; Subramaniapillai M; Shekotikhina M; Rong C; Lee Y; McIntyre RS
    CNS Neurol Disord Drug Targets; 2017; 16(8):891-899. PubMed ID: 28933261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive dysfunction in unipolar depression: implications for treatment.
    Trivedi MH; Greer TL
    J Affect Disord; 2014 Jan; 152-154():19-27. PubMed ID: 24215896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine alterations and cognitive impairment in major depressive disorder: From putative mechanisms to novel treatment targets.
    Misiak B; Beszłej JA; Kotowicz K; Szewczuk-Bogusławska M; Samochowiec J; Kucharska-Mazur J; Frydecka D
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):177-188. PubMed ID: 28433456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Cognitive Impairment on Functioning in Patients With Depression.
    Lam RW
    J Clin Psychiatry; 2017; 78(9):e1430. PubMed ID: 29345878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive dysfunctions in depression - significance, description and treatment prospects.
    Czerwińska A; Pawłowski T
    Psychiatr Pol; 2020 Jun; 54(3):453-466. PubMed ID: 33038880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment in major depressive disorder.
    Pan Z; Park C; Brietzke E; Zuckerman H; Rong C; Mansur RB; Fus D; Subramaniapillai M; Lee Y; McIntyre RS
    CNS Spectr; 2019 Feb; 24(1):22-29. PubMed ID: 30468135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive dysfunction in major depressive disorder.
    Knight MJ; Baune BT
    Curr Opin Psychiatry; 2018 Jan; 31(1):26-31. PubMed ID: 29076892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring cognitive function in MDD: emerging assessment tools.
    Russo M; Mahon K; Burdick KE
    Depress Anxiety; 2015 Apr; 32(4):262-9. PubMed ID: 25421437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Available Tools for Assessing Cognitive Impairment in Major Depressive Disorder.
    McIntyre RS
    J Clin Psychiatry; 2017; 78(9):e1427. PubMed ID: 29345875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive Impairment in Major Depressive Disorder: A Case Discussion Illustrating Impact, Assessment, and Management.
    Culpepper L; Lam RW; McIntyre RS
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29505194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired visual, working, and verbal memory in first-episode, drug-naive patients with major depressive disorder in a Chinese population.
    Chen C; Jiang WH; Wang W; Ma XC; Li Y; Wu J; Hashimoto K; Gao CG
    PLoS One; 2018; 13(4):e0196023. PubMed ID: 29684091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target.
    Goeldner C; Ballard TM; Knoflach F; Wichmann J; Gatti S; Umbricht D
    Neuropharmacology; 2013 Jan; 64():337-46. PubMed ID: 22992331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vortioxetine: A Review in Cognitive Dysfunction in Depression.
    Frampton JE
    Drugs; 2016 Nov; 76(17):1675-1682. PubMed ID: 27807822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognition in major depressive disorder: a 'Systemically Important Functional Index' (SIFI).
    McIntyre RS; Lee Y
    Curr Opin Psychiatry; 2016 Jan; 29(1):48-55. PubMed ID: 26575300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical management of major depressive disorder.
    Mignon L; Stahl SM
    CNS Spectr; 2009 Nov; 14(11 Suppl 10):3-6; quiz 7-8. PubMed ID: 20173690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.
    Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.